Consensus Recommendations for the Use of Hyperdiluted Calcium Hydroxyapatite (Radiesse) as a Face and Body Biostimulatory Agent

Ada Trindade de Almeida, Vinicius Figueredo, Ana Lúcia Gonzaga da Cunha, Gabriela Casabona, Joana Ribeiro Costa de Faria, Emerson Vicente Alves, Mauricio Sato, Adeíza Branco, Christine Guarnieri, Eliandre Palermo, Ada Trindade de Almeida, Vinicius Figueredo, Ana Lúcia Gonzaga da Cunha, Gabriela Casabona, Joana Ribeiro Costa de Faria, Emerson Vicente Alves, Mauricio Sato, Adeíza Branco, Christine Guarnieri, Eliandre Palermo

Abstract

Background: Calcium hydroxyapatite (CaHA) is a well-established collagen stimulator. In recent years, it has been increasingly used in hyperdiluted form as a biostimulatory agent rather than a volumizing filler to improve skin quality and firmness in both facial and corporal areas. However, guidelines on the techniques required to achieve optimal results are still lacking. The objective of this study was to develop a consensus recommendation for the safe and effective use of hyperdiluted CaHA for face and body biostimulation.

Methods: A team of 10 experts with extensive experience in dermal fillers and biostimulatory treatments for facial and body rejuvenation convened for a live meeting. Consensus was defined as approval by 70%-89% of all participants, whereas agreement of ≥90% denoted strong consensus.

Results: For most items, the group achieved a majority consensus. Recommendations have been provided for the face, neck, décolletage, buttocks, thighs, arms, abdomen, knees, and elbows with detailed injection techniques, providing information on insertion points, dosages, and volumes for both needle and cannula injections as well as the number of treatment sessions and intervals.

Conclusions: The expert consensus supports and provides guidance for the use of CaHA as a biostimulatory agent for face and body rejuvenation. However, further clinical studies are necessary to provide physicians with the best evidence for the best treatment practices.

Figures

Fig. 1.
Fig. 1.
The face before and 8 weeks after injections of 1.5 mL of CaHA (Radiesse) diluted 1:1 with 1.5 mL of lidocaine (total of 3 syringes split in 2 sessions with a 4-week interval). Notice the improvement of skin laxity and the discrete volume gain. Courtesy of Vinicius Figueredo, MD.
Fig. 2.
Fig. 2.
Techniques for CaHA biostimulation of the face.
Fig. 3.
Fig. 3.
Techniques for CaHA biostimulation of the neck.
Fig. 4.
Fig. 4.
Techniques for CaHA application in the buttocks.
Fig. 5.
Fig. 5.
Techniques for CaHA application in the abdomen.
Fig. 6.
Fig. 6.
The upper arm before and 48 weeks after injection of 1.5 mL of CaHA (Radiesse) diluted with 6 mL of lidocaine, per side. Notice the remarkable long-term improvement of skin laxity. Courtesy of Eliandre Palermo, MD.
Fig. 7.
Fig. 7.
Technique for CaHA application in the arm.
Fig. 8.
Fig. 8.
Techniques for CaHA application in the knee.

References

    1. Kadouch JA. Calcium hydroxylapatite: a review on safety and complications. J Cosmet Dermatol. 2017;16:152–161.
    1. Loghem JV, Yutskovskaya YA, Philip Werschler W. Calcium hydroxylapatite: over a decade of clinical experience. J Clin Aesthet Dermatol. 2015;8:38–49.
    1. Carruthers J, Burgess C, Day D, et al. Consensus recommendations for combined aesthetic interventions in the face using botulinum toxin, fillers, and energy-based devices. Dermatol Surg. 2016;42:586–597.
    1. Berlin AL, Hussain M, Goldberg DJ. Calcium hydroxylapatite filler for facial rejuvenation: a histologic and immunohistochemical analysis. Dermatol Surg. 2008;34(suppl 1):S64–S67.
    1. Tzikas TL. A 52-month summary of results using calcium hydroxylapatite for facial soft tissue augmentation. Dermatol Surg. 2008;34(suppl 1):S9–S15.
    1. Silvers SL, Eviatar JA, Echavez MI, et al. Prospective, open-label, 18-month trial of calcium hydroxylapatite (Radiesse) for facial soft-tissue augmentation in patients with human immunodeficiency virus-associated lipoatrophy: one-year durability. Plast Reconstr Surg. 2006;118(suppl):34S–45S.
    1. Yutskovskaya YA, Kogan EA. Improved neocollagenesis and skin mechanical properties after injection of diluted calcium hydroxylapatite in the neck and décolletage: a pilot study. J Drugs Dermatol. 2017;16:68–74.
    1. Fabi SG, Burgess C, Carruthers A, et al. Consensus recommendations for combined aesthetic interventions using botulinum toxin, fillers, and microfocused ultrasound in the neck, décolletage, hands, and other areas of the body. Dermatol Surg. 2016;42:1199–1208.
    1. Coleman KM, Voigts R, DeVore DP, et al. Neocollagenesis after injection of calcium hydroxylapatite composition in a canine model. Dermatol Surg. 2008;34(suppl 1):S53–S55.
    1. Yutskovskaya Y, Kogan E, Leshunov E. A randomized, split-face, histomorphologic study comparing a volumetric calcium hydroxylapatite and a hyaluronic acid-based dermal filler. J Drugs Dermatol. 2014;13:47–52.
    1. Courderot-Masuyer C, Robin S, Tauzin H, et al. Evaluation of lifting and antiwrinkle effects of calcium hydroxylapatite filler. In vitro quantification of contractile forces of human wrinkle and normal aged fibroblasts treated with calcium hydroxylapatite. J Cosmet Dermatol. 2016;15:260–268.
    1. Casabona G, Pereira G. Microfocused ultrasound with visualization and calcium hydroxylapatite for improving skin laxity and cellulite appearance. Plast Reconstr Surg Glob Open. 2017;5:e1388.
    1. Pavicic T. Complete biodegradable nature of calcium hydroxylapatite after injection for malar enhancement: an MRI study. Clin Cosmet Investig Dermatol. 2015;8:19–25.
    1. Wasylkowski VC. Body vectoring technique with Radiesse for tightening of the abdomen, thighs, and brachial zone. Clin Cosmet Investig Dermatol. 2015;8:267–273.
    1. Amselem M. Radiesse: a novel rejuvenation treatment for the upper arms. Clin Cosmet Investig Dermatol. 2015;9:9–14.
    1. Grunebaum LD, Elsaie ML, Kaufman J. Six-month, double-blind, randomized, split-face study to compare the efficacy and safety of calcium hydroxylapatite (CaHA) mixed with lidocaine and CaHA alone for correction of nasolabial fold wrinkles. Dermatol Surg. 2010;36:760–765.
    1. van Loghem JA, Humzah D, Kerscher M. Cannula versus sharp needle for placement of soft tissue fillers: an observational cadaver study. Aesthet Surg J. 2017;38:73–88.
    1. Pavicic T, Frank K, Erlbacher K, et al. Precision in dermal filling: a comparison between needle and cannula when using soft tissue fillers. J Drugs Dermatol. 2017;16:866–872.
    1. Beer K. Dermal fillers and combinations of fillers for facial rejuvenation. Dermatol Clin. 2009;27:427–432, v.
    1. Carruthers J, Carruthers A. Botulinum toxin A in the mid and lower face and neck. Dermatol Clin. 2004;22:151–158.
    1. Rohrich RJ, Pessa JE. The fat compartments of the face: anatomy and clinical implications for cosmetic surgery. Plast Reconstr Surg. 2007;119:2219–2227; discussion 2228.
    1. Rohrich RJ, Pessa JE, Ristow B. The youthful cheek and the deep medial fat compartment. Plast Reconstr Surg. 2008;121:2107–2112.
    1. Casabona G. Combined use of microfocused ultrasound and a calcium hydroxylapatite dermal filler for treating atrophic acne scars: a pilot study. J Cosmet Laser Ther. 2018;5:301–306.
    1. Chao YY, Chiu HH, Howell DJ. A novel injection technique for horizontal neck lines correction using calcium hydroxylapatite. Dermatol Surg. 2011;37:1542–1545.
    1. Mazzuco R, Sadick NS. The use of poly-L-lactic acid in the gluteal area. Dermatol Surg. 2016;42:441–443.
    1. Goldberg DJ, Hornfeldt CS. Safety and efficacy of microfocused ultrasound to lift, tighten, and smooth the buttocks. Dermatol Surg. 2014;40:1113–1117.
    1. Sasaki G, Tevez A. Microfocused ultrasound for nonablative skin and subdermal tightening to the periorbitum and body sites: preliminary report on eighty-two patients. J Cosmet Dermatol Sci Appl. 2012;2:109–116.
    1. Cogorno Wasylkowski V. Body vectoring technique with Radiesse for tightening of the abdomen, thighs, and brachial zone. Clin Cosmet Investig Dermatol. 2015;8:267–273.
    1. Lapatina NG, Pavlenko T. Diluted calcium hydroxylapatite for skin tightening of the upper arms and abdomen. J Drugs Dermatol. 2017;16:900–906.
    1. Day D. Counseling patients on facial volume replacement and adherence with posttreatment instructions. Patient Prefer Adherence. 2010;4:273–281.
    1. Funt D, Pavicic T. Dermal fillers in aesthetics: an overview of adverse events and treatment approaches. Clin Cosmet Investig Dermatol. 2013;6:295–316.
    1. Jacovella PF. Use of calcium hydroxylapatite (Radiesse) for facial augmentation. Clin Interv Aging. 2008;3:161–174.

Source: PubMed

3
订阅